Logo image
An Amplitude-Integrated EEG Evaluation of Neonatal Opioid Withdrawal Syndrome
Journal article   Peer reviewed

An Amplitude-Integrated EEG Evaluation of Neonatal Opioid Withdrawal Syndrome

Christopher Lust, Zachary Vesoulis, John Zempel, Hongjie Gu, Stephanie Lee, Rakesh Rao and Amit M. Mathur
American journal of perinatology, Vol.41(S 01), pp.e290-e297
05/01/2024
DOI: 10.1055/a-1877-9291
PMCID: PMC10008470
PMID: 35709730
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC10008470/pdf/nihms-1834231.pdfView
Open Access

Abstract

Objective Infants with neonatal opioid withdrawal syndrome (NOWS) have disrupted neurobehavior that requires hospitalization and treatment. This article aimed to evaluate electroencephalography (EEG) abnormalities using amplitude-integrated EEG (aEEG) in NOWS. Study Design Eighteen term born infants with NOWS were recruited prospectively for an observational pilot study. aEEG monitoring was started within 24 hours of recruitment and twice weekly through discharge. aEEG data were analyzed for background and seizures. Severity of withdrawal was monitored using the modified Finnegan scoring (MFS) system. Results Fifteen neonates had complete datasets. Thirteen (87%) had continuous aEEG background in all recordings. None had sleep-wake cyclicity (SWC) at initial recording. Brief seizures were noted in 9 of 15 (60%) infants. Lack of SWC was associated with higher MFS scores. At discharge, 8 of 15 (53%) had absent or emerging SWC. Conclusion aEEG abnormalities (absent SWC) are frequent and persist despite treatment at the time of discharge in the majority of patients with NOWS. Brief electrographic seizures are common. Neonates with persistent aEEG abnormalities at discharge warrant close follow-up.
Life Sciences & Biomedicine Obstetrics & Gynecology Pediatrics Science & Technology

Details

Metrics

Logo image